- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 239/00 - Compounds containing nitrogen-to-halogen bondsHydroxylamino compounds or ethers or esters thereof
Patent holdings for IPC class C07C 239/00
Total number of patents in this class: 89
10-year publication summary
1
|
2
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Takeda Pharmaceutical Company Limited | 2702 |
9 |
Takeda Pharmaceuticals U.S.A., Inc. | 178 |
6 |
Boehringer Ingelheim International GmbH | 4720 |
3 |
Les Laboratoires Servier | 544 |
3 |
MPC Merger Sub, Inc. | 12 |
3 |
MPC Oldco, Inc. | 11 |
3 |
The University of North Carolina at Chapel Hill | 2000 |
3 |
BASF SE | 20548 |
2 |
Massachusetts Institute of Technology | 9925 |
2 |
E. R. Squibb & Sons, L.L.C. | 121 |
2 |
GE Healthcare AS | 233 |
2 |
Mutual Pharmaceutical Company, Inc. | 26 |
2 |
Shandong Luye Pharmaceutical Co., Ltd. | 62 |
2 |
Youxin Li | 3 |
2 |
Bristol-myers Squibb Company | 4849 |
1 |
Syngenta Participations AG | 2038 |
1 |
DSM IP Assets B.V. | 5570 |
1 |
Vertex Pharmaceuticals Incorporated | 1582 |
1 |
University of Florida Research Foundation, Inc. | 3959 |
1 |
AMOREPACIFIC Corporation | 2800 |
1 |
Other owners | 39 |